Risultati di ricerca
Tasuku Honjo è un medico giapponese. Docente dal 2005 di Immunologia presso l’Università di Kyoto, con solide esperienze di ricerca negli Stati Uniti presso la Carnegie Institution of Washington e i National Institutes of Health, nel 1992 ha individuato la proteina PD-1, recettore che inibisce il riconoscimento delle cellule ...
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
1 ott 2018 · 01 October 2018. Cancer immunologists scoop medicine Nobel prize. James Allison and Tasuku Honjo pioneered treatments that unleash the body’s own immune system to attack cancer cells. By. Heidi...
- Heidi Ledford, Holly Else, Matthew Warren
- 2018
9 mag 2024 · Tasuku Honjo, Japanese immunologist who contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses and whose work led to the development of novel immunotherapies against cancer. Honjo received a share of the 2018 Nobel Prize for Physiology or Medicine.
- Kara Rogers
Tasuku HONJO, Head of Department | Cited by 77,615 | of Kyoto University, Kyoto (Kyodai) | Read 544 publications | Contact Tasuku HONJO
Tasuku Honjo. Deputy Director-General and Distinguished Professor. View more details. Research Fields. Molecular Immunology. Research Overview. Honjo is well known for his discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.
Telephone interview with Tasuku Honjo following the announcement of the 2018 Nobel Prize in Physiology or Medicine on 1 October 2018. The interviewer is Adam Smith, Chief Scientific Officer of Nobel Media.
